藤井 伸治 ふじい のぶはる 先生

来歴等

略歴

1995年 高知大学医学部 卒業
1995年 岡山大学医学部附属病院 第二内科 研修医
1996年 岡山赤十字病院 内科研修医
1997年 広島赤十字原爆病院 第4内科レジデント
1998年 岡山大学医学部附属病院 第二内科 医員
1999年 岡山大学医学部附属病院 輸血部 医員
2000年 岡山大学 第二内科 研究生
2002年 岡山大学病院 医員（血液腫瘍内科）
2003年 岡山大学病院 助手（血液腫瘍内科）
2006年 フレッドハッチンソン癌センター 研究員
2009年 岡山大学病院 医員（血液腫瘍内科）
2010年 岡山大学病院 助教（血液腫瘍内科）
2011年 岡山大学病院 講師（輸血部）
2023年 岡山大学病院 准教授（輸血部）

論文

• 1. DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells. Blood. 2008 May 1;111(9):4817-26. Epub 2008 Feb 25.

  Rosinski KV, Fujii N, Mito JK, Koo KK, Xuereb SM, Sala-Torra O, Gibbs JS, Radich JP, Akatsuka Y, Van den Eynde BJ, Riddell SR, Warren EH.

• 2. C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients. Clinical Cancer Research 2008 Aug 15;14(16):5260-9.

  Tykodi SS, Fujii N, Vigneron N, Lu SM, Mito JK, Miranda MX, Chou J, Voong LN, Thompson JA, Sandmaier BM, Cresswell P, Van den Eynde BJ, Riddell SR, Warren EH.

• 3. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplant with T cells specific for minor histocompatibility antigens. Blood. 2010 Jan 13

  Warren EH, Fujii N, Akatsuka Y, Chaney CN, Mito JK, Loeb KR, Gooley TA, Brown ML, Koo KK, Rosinski KV, Ogawa S, Matsubara A, Appelbaum FR, Riddell SR.

• 4. A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity. 2009 Nov 20;31(5):834-44. Epub 2009 Oct 29.

  Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR.

• 5. Bronchiolitis obliterans with allogeneic hematopoietic cell transplantation: a 10-year experience of the Okayama BMT Group. Int J Hematol. 2014;99: 644-51.

  Fujii N, Nakase K, Asakura S, Matsuo K, Nawa Y, Sunami K, Nishimori H, Matsuoka K, Kondo E, Maeda Y, Shinagawa K, Hara M, Tanimoto M.

• 6. Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation. Int J Hematol. 2018 Dec;108(6):622-629.

  Nakamura M, Fujii N, Shimizu K, Ikegawa S, Seike K, Inomata T, Sando Y, Fujii K, Nishimori H, Matsuoka KI, Morimatsu H, Maeda Y.

• 7. Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation. Transfusion. 2020 Mar;60(3):473-478.

  Seike K, Fujii N, Asano N, Ohkuma S, Hirata Y, Fujii K, Sando Y, Nakamura M, Naito K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Matsuoka KI, Tsubaki K, Otsuka F, Maeda Y.

• 8. Characterization of localized macrophages in bronchiolitis obliterans after allogeneic hematopoietic cell transplantation. Int J Hematol. 2021 Sep 7.

  Kuroi T, Fujii N, Ichimura K, Seike K, Yamamoto A, Kambara Y, Sugimoto S, Otani S, Saeki K, Fujiwara H, Nishiomori H, Oto T, Maeda Y.

• 9. Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma. Int J Clin Oncol. 2021 Oct 1.

  Kato K, Makita S, Goto H, Kanda J, Fujii N, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K.

• 10. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation.　Int J Hematol. 2023　Apr;　117(4):578-589.

  Kambara Y, Fujii N, Usui Y, Yamamoto A, Higo H, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y.

• 11. Bone marrow microenvironment disruption and sustained inflammation with prolonged haematologic toxicity after CAR T-cell therapy. Br J Haematol. 2023 Jul;202(2):294-307.

  Kitamura W, Asada N, Naoi Y, Abe M, Fujiwara H, Ennishi D, Nishimori H, Fujii K, Fujii N, Matsuoka KI, Yoshino T, Maeda Y.

• 12. Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan.　Int J Clin Oncol. 2023 Jun;28(6):816-826.

  Goto H, Kitawaki T, Fujii N, Kato K, Onishi Y, Fukuhara N, Yamauchi T, Toratani K, Kobayashi H, Yoshida S, Shimo M, Onodera K, Senjo H, Onozawa M, Hirata K, Yokota I, Teshima T.

• 13. Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation.　Int J Hematol. 2023 Aug;118(2):242-251.

  Fujii N, Onizuka M, Fukuda T, Ikegame K, Kawakita T, Nakamae H, Kobayashi T, Kataoka K, Tanaka M, Kondo T, Kato K, Sato A, Ichinohe T, Atsuta Y, Ogata M, Suzuki R, Nakasone H; JSTCT Transplant Complications Working Group.

• 14. Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel. Transplant Cell Ther. 2023 Sep;29(9):573.e1-573.e8.

  Terao T, Kitamura W, Fujii N, Asada N, Kamoi C, Fujiwara K, Kondo K, Matsubara C, Hayashino K, Seike K, Fujiwara H, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y.